FDA's Hahn Apologizes For Overselling Plasma's Benefits As A COVID-19 Treatment

The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.